Olderbak Sally, Möckl Justin, Rauschert Christian, Schäfer Evita, Helmer Stefanie, Seitz Nicki-Nils, Hoch Eva
IFT Center for Mental Health & Addiction Research, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians- University, Munich, Germany.
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):389-396. doi: 10.1007/s00406-024-01861-5. Epub 2024 Jul 6.
During the Covid-19 pandemic Germany experienced its first increase in the proportion of heavy cannabis users since 1995. With the expected nationwide decriminalization of cannabis before 2025, we investigate the potential causes for that increase. Data were from the 2021 European Web Survey on Drugs (EWSD) including 762 12-month marijuana users from Germany (72.9% male, mean age = 29.5 years). Both heavy and regular cannabis consumers reported an increase in marijuana consumption during the pandemic, with infrequent users reporting a decrease. Using multinomial logistic regression, we found younger individuals (OR = 0.95 [95% CI = 0.92, 0.98]) and those not pursuing or completing higher education (OR = 1.86 [1.23, 2.81]) had increased use. Additionally, using cannabis to self-medicate (OR = 2.79 [1.56, 4.99]) and purchasing marijuana (OR = 2.26 [1.35, 3.77]) was associated with increased use. We found, relative to infrequent users, both regular (OR = 4.00 [2.39, 6.72]) and notably heavy users (OR = 31.17 [12.10, 80.32]) were more likely to use cannabis to self-medicate. Both regular (OR = 4.09 [2.47, 6.77]) and especially heavy users (OR = 13.53 [6.74, 27.16]) were also more likely to purchase marijuana. Heavy users were also more likely to be past 30-day tobacco users (OR = 5.92 [2.81, 12.45]). We identified the self-reported motivation of using cannabis to self-medicate as well as act of purchasing marijuana as having the strongest relation to being a heavy user and increasing marijuana use during the Covid-19 pandemic.
在新冠疫情期间,德国自1995年以来首次出现重度大麻使用者比例上升的情况。鉴于预计到2025年前大麻将在全国范围内合法化,我们对这一增长的潜在原因进行了调查。数据来自2021年欧洲药物网络调查(EWSD),其中包括762名来自德国的过去12个月内使用大麻的人(72.9%为男性,平均年龄 = 29.5岁)。重度和经常使用大麻的消费者均报告在疫情期间大麻消费量增加,而不经常使用大麻的人则报告消费量减少。通过多项逻辑回归分析,我们发现年龄较小的个体(比值比[OR] = 0.95 [95%置信区间[CI] = 0.92, 0.98])以及未追求或完成高等教育的人(OR = 1.86 [1.23, 2.81])使用量增加。此外,使用大麻进行自我治疗(OR = 2.79 [1.56, 4.99])和购买大麻(OR = 2.26 [1.35, 3.77])与使用量增加有关。我们发现,相对于不经常使用大麻的人,经常使用大麻的人(OR = 4.00 [2.39, 6.72]),尤其是重度使用者(OR = 31.17 [12.10, 80.32])更有可能使用大麻进行自我治疗。经常使用大麻的人(OR = 4.09 [2.47, 6.77]),特别是重度使用者(OR = 13.53 [6.74, 27.16])也更有可能购买大麻。重度使用者也更有可能是过去30天内的烟草使用者(OR = 5.92 [2.81, 12.45])。我们确定,自我报告的使用大麻进行自我治疗的动机以及购买大麻的行为与在新冠疫情期间成为重度使用者和增加大麻使用量的关系最为密切。